ALFA FinderBSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹25.03
- Market cap
- ₹1,734 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 58.2×Sector 28.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
- Value
- ₹26.95 Cr
Other board meeting date announcements
All →Vikram Solar Board Meeting Date
Vikram Solar scheduled a board meeting for November 14, 2026 to consider Q2FY27 results. The trading window remains closed until 48 hours after results are disclosed.
Aqylon Nexus Board Meeting Date
Aqylon Nexus will hold a board meeting on November 14, 2026 to consider quarterly results. Trading window closure applies until 48 hours after results.
K&R Rail Engineering Board Meeting Date
K&R Rail Engineering will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The meeting is a future notice with the agenda proposed only.
Abha Power and Steel Board Meeting Date
Abha Power and Steel will hold a board meeting on 14 November 2026 to approve unaudited standalone half-yearly results for September 2026. The trading window is closed from 1 October to 16 November 2026.
Valplast Technologies Board Meeting Date
Valplast Technologies schedules a 14 November 2026 board meeting for unaudited half-year results. The trading window stays closed until 16 November 2026.
Aris International Board Meeting Date
Aris International has scheduled a board meeting on 14 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. No financial figures are disclosed in this prior intimation.